Ascendis Pharma A/S (ASND)

222.99 -4.01 (-1.77%) USD  |  NASDAQ  |  Oct 13, 15:22
More

Ascendis Pharma EPS Estimates for 2 Fiscal Years Ahead

EPS Estimates for 2 Fiscal Years Ahead Chart

View EPS Estimates for 2 Fiscal Years Ahead for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for 2 Fiscal Years Ahead Data

View and export this data back to 2026. Start Trial.
Date Value
September 15, 2026 --
August 14, 2026 --
August 13, 2026 --
July 16, 2026 --
July 09, 2026 --
Date Value
May 08, 2026 --
May 07, 2026 --
May 05, 2026 --
April 23, 2026 --
April 21, 2026 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years

View EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for 2 Fiscal Years Ahead Benchmarks

View EPS Estimates for 2 Fiscal Years Ahead Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Novo Nordisk A/S Upgrade
Evaxion AS Upgrade
Genmab A/S Upgrade
Zealand Pharma A/S --